CATEGORIES

Healthcare

LATEST

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

When It Comes to the Future of HLTH – Life Is Not a Las Vegas Roulette Wheel

The Gambling Capital of the World is an Ideal Setting for Health-Sector Predictions

The Fluoroscope Serves as a Warning for New Medical Technology

What does a device called the Fluoroscope that measured feet have in common with modern-day DNA medicines? History has a way of repeating

The Wearables Expert ™ Interviews Lucien Engelen

Episode 9. João Bocas - The Wearables Expert ™ Interviews Lucien Engelen on Digital Health, AI, Big Tech and Innovation